Related Experiment Video
Updated: Jun 12, 2026

Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome
Published on: October 3, 2018
[Anemia with aplastic anemia, paroxysmal nocturnal hemoglobinuria and myelodysplastic syndromes]
1Service d'Hématologie, Hôpitaux Universitaires de Genève. jakob.passweg@hcuge.ch
Abstract:
This review discusses aplastic anemia (AA), paroxysmal nocturnal hemoglobinuria (PNH) and the myelodysplastic syndrome (MDS, all diseases associated with severe anemia. Anemia in AA and MDS is mainly due to defective or lacking eryhtropoiesis in the case of PNH mostly due to hemolysis. Management by transfusions, the use of growth factors and iron chelation is being discussed as are more specific treatment approaches directed against the underlying disease.
Related Concept Videos
Disorders of Erythrocytes
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Disorders of Leukocytes
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune system...
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Erythropoiesis
Differentiation of Common Myeloid Progenitor Cells

